CureVac is a leading biopharmaceutical company based in Boston, MA, dedicated to developing groundbreaking medications using RNA technology. With a focus on protecting and improving people's lives, CureVac leverages its two decades of scientific and production excellence to develop innovative treatments that enable the body to produce its own prophylactic and therapeutic drugs.
Driven by their RNA technology platform, CureVac is committed to advancing the field of medicine and revolutionizing the way medications are developed and administered.
Generated from the website